Diflunisal



Indications and Reactions:

Role Indications Reactions
Primary
Pain 33.3%
Arthralgia 16.7%
Arthritis 16.7%
Neuropathy Peripheral 16.7%
Rheumatoid Arthritis 16.7%
Urticaria 25.0%
Blood Urine Present 12.5%
Coeliac Disease 12.5%
Drug Prescribing Error 12.5%
Feeling Abnormal 12.5%
Nausea 12.5%
Paraesthesia 12.5%
Secondary
Product Used For Unknown Indication 68.5%
Drug Use For Unknown Indication 6.5%
Chest Pain 4.3%
Hypertension 3.3%
Diabetes Mellitus 2.2%
Rheumatoid Arthritis 2.2%
Suicide Attempt 2.2%
Antidepressant Therapy 1.1%
Anxiety 1.1%
Atrial Fibrillation 1.1%
Breast Cancer 1.1%
Dyslipidaemia 1.1%
Dyspepsia 1.1%
Fatigue 1.1%
Gastrooesophageal Reflux Disease 1.1%
Hyperlipidaemia 1.1%
Myalgia 1.1%
Completed Suicide 34.2%
Respiratory Arrest 7.9%
Toxicity To Various Agents 7.9%
Cardiac Arrest 5.3%
Drug Hypersensitivity 5.3%
Visual Impairment 5.3%
Abdominal Discomfort 2.6%
Blood Creatine Phosphokinase Increased 2.6%
Cardiac Failure Congestive 2.6%
Cardio-respiratory Arrest 2.6%
Death 2.6%
Drug Toxicity 2.6%
Gastric Haemorrhage 2.6%
Interstitial Lung Disease 2.6%
Poisoning 2.6%
Renal Failure Acute 2.6%
Suicide Attempt 2.6%
Tremor 2.6%
Vascular Anomaly 2.6%
Concomitant
Product Used For Unknown Indication 30.8%
Rheumatoid Arthritis 15.7%
Hypertension 8.5%
Drug Use For Unknown Indication 8.2%
Pain 7.1%
Hepatitis C 4.6%
Arthritis 3.9%
Osteoporosis 2.9%
Hypersensitivity 2.3%
Gastrooesophageal Reflux Disease 2.2%
Insomnia 2.0%
Diabetes Mellitus 1.7%
Ulcer 1.5%
Smoking Cessation Therapy 1.4%
Arthralgia 1.2%
Back Pain 1.2%
Blood Cholesterol Increased 1.2%
Depression 1.2%
Vitamin Supplementation 1.2%
Bipolar Disorder 1.1%
Vitreous Floaters 12.9%
Vomiting 8.6%
Wrist Surgery 7.1%
Diarrhoea 5.7%
Malaise 5.7%
Somnolence 5.7%
Anaemia 4.3%
Inappropriate Schedule Of Drug Administration 4.3%
Nausea 4.3%
Pancreatitis 4.3%
Paraesthesia 4.3%
Platelet Count Decreased 4.3%
Sedation 4.3%
Urinary Tract Infection 4.3%
Weight Increased 4.3%
Withdrawal Syndrome 4.3%
Agitation 2.9%
Arthralgia 2.9%
Cardiac Failure 2.9%
Cellulitis 2.9%